Invention Grant
US09458213B2 Compositions and methods for diagnosing prostate cancer based on detection of SLC45A3-ELK4 fusion transcript
有权
基于检测SLC45A3-ELK4融合转录物诊断前列腺癌的组合物和方法
- Patent Title: Compositions and methods for diagnosing prostate cancer based on detection of SLC45A3-ELK4 fusion transcript
- Patent Title (中): 基于检测SLC45A3-ELK4融合转录物诊断前列腺癌的组合物和方法
-
Application No.: US13202207Application Date: 2010-02-19
-
Publication No.: US09458213B2Publication Date: 2016-10-04
- Inventor: Mark A. Rubin , Dorothee Pflueger , David S. Rickman
- Applicant: Mark A. Rubin , Dorothee Pflueger , David S. Rickman
- Applicant Address: US NY Ithaca
- Assignee: CORNELL UNIVERSITY
- Current Assignee: CORNELL UNIVERSITY
- Current Assignee Address: US NY Ithaca
- Agency: Scully, Scott, Murphy & Presser, P.C.
- International Application: PCT/US2010/024748 WO 20100219
- International Announcement: WO2010/096660 WO 20100826
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07K14/47 ; C12N15/62
Abstract:
RNA transcripts representing a fusion of a human SLC45A3 nucleic acid and a human ELK4 nucleic acid that are associated with prostate cancer are described. Compositions and methods useful for detection of fusion transcripts of human SLC45A3 and ELK4 genetic sequences associated with cancer and useful for cancer therapy are provided.
Public/Granted literature
Information query
